Preventing Bacterial and Viral Infections Among Injection Drug Users
2 other identifiers
interventional
252
1 country
2
Brief Summary
We propose a randomized controlled trial (RCT) of the Skin intervention, compared to an assessment-only condition (both groups receive rapid HIV testing, a review of testing results, and brief HIV prevention counseling) among 350 injection drug users recruited during an acute medical hospitalization at Boston Medical Center. In the general hospital setting, injection drug users who otherwise might not seek care are accessible and teachable, and the presence of a drug-related illness can set the stage for patients to be more receptive to interventions2. We hypothesize that the Skin intervention will produce better outcomes at 1-, 3-, 6-, 9-, and 12-month(s) post-intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2013
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2013
CompletedFirst Posted
Study publicly available on registry
July 4, 2013
CompletedStudy Start
First participant enrolled
September 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedJune 9, 2020
June 1, 2020
5.9 years
July 1, 2013
June 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
bacterial infections
one year
high-risk behavior
one year
health service use
one year
Study Arms (2)
SKIN Intervention
ACTIVE COMPARATORParticipants will receive the SKIN intervention at Baseline and 1-mo interviews.
Assessment-Only
PLACEBO COMPARATORParticipants in this arm will receive treatment-as-usual
Interventions
Eligibility Criteria
You may qualify if:
- years of age or older
- report injection of heroin, cocaine, or methamphetamine (meth) on at least three different days in the week prior to admission
- have injected heroin, cocaine, or meth for at least three months
- positive urine screen for heroin, cocaine, or meth
You may not qualify if:
- currently psychotic (e.g., responding to internal stimuli through observed hallucinations or delusions), homicidal or suicidal
- cannot provide informed consent
- not able to complete interviews in English (expected to exclude \<5% of IDUs)
- in police custody, expecting incarceration
- unable to provide names and contact information for at least two verifiable locator persons who will know where to find them for retention/follow-up purposes
- plan to move out of the Boston area in the next 12 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Butler Hospitallead
Study Sites (2)
Boston Medical Center
Boston, Massachusetts, United States
Butler Hospital
Providence, Rhode Island, 02906, United States
Related Publications (2)
Freibott CE, Phillips KT, Anderson BJ, Stewart C, Liebschutz JM, Stein MD. Under the Skin: The Relationship Between Subcutaneous Injection and Skin Infections Among People Who Inject Drugs. J Addict Med. 2022 Mar-Apr 01;16(2):164-168. doi: 10.1097/ADM.0000000000000844.
PMID: 33813580DERIVEDStein MD, Phillips KT, Herman DS, Keosaian J, Stewart C, Anderson BJ, Weinstein Z, Liebschutz J. Skin-cleaning among hospitalized people who inject drugs: a randomized controlled trial. Addiction. 2021 May;116(5):1122-1130. doi: 10.1111/add.15236. Epub 2020 Sep 21.
PMID: 32830383DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 1, 2013
First Posted
July 4, 2013
Study Start
September 1, 2013
Primary Completion
August 1, 2019
Study Completion
January 1, 2020
Last Updated
June 9, 2020
Record last verified: 2020-06